The REgistry of Very Early Estrogen and AnovuLation

ConditionsHypothalamic Amenorrhea, Functional Hypothalamic Amenorrhea Functional Hypogonadotropic Hypogonadism

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexFemale

Age18-40

SponsorMayo Clinic

About this trial

The purpose of this study is to to build a registry of women with early estrogen loss due to Functional Hypothalamic Amenorrhea (FHA) to understand the prevalence, racial and ethnic diversity of this condition.

Eligibility criteria

Qualifiers

Estradiol: < 50pg/mL

LH: < 10 IU/mL

FSH: < 10 IU

Testosterone: 2 - 45 ng/dL

Disqualifiers

Parturition/lactating in the last 6-12 months

Lack of consent

Trial design

Treatments tested in this trial

Automated Self-Administered 24-hour Dietary Assessment Tool (ASA24)
REVEAL Questionnaire

Treatment groups

100,000 Participants

are divided into 1 treatment group

Sponsors and collaborators

Mayo Clinic

Lead sponsor

Source ClinicalTrials.gov